Pfizer (PFE) Tops Q1 EPS by 15c, Guidance Misses Consensus

Pfizer (NYSE: PFE) reported Q1 EPS of $1.62, $0.15 better than the analyst estimate of $1.47. Revenue for the quarter came in at $25.7 billion versus the consensus estimate of $23.86 billion.

GUIDANCE:

Pfizer sees FY2022 EPS of $6.25-$6.45, versus the consensus of $7.15. Pfizer sees FY2022 revenue of $98-102 billion, versus the consensus of $107.9 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
• ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance